MAR 20, 2015 10:44 AM PDT

Alzheimer's Drug Slows Cognitive Decline

WRITTEN BY: Judy O'Rourke
Biogen Idec Inc, Cambridge, Mass, says aducanumab, its new Alzheimer's drug under development shows signs of slowing the decline of a small number of patients with early indications and mild cases of the disease, according to The Boston Globe.

The company says its testing yielded "statistically significant" evidence the drug slows the decline of certain patients and reduced amyloid plaque in the brain (implicated in the development of Alzheimer's symptoms).
Beta-amyloid is chemically
Biogen says it plans to advance the drug compound to late-stage clinical trials, with FDA approval, and would start to enroll patients later this year.

The newspaper reports the company presented more detailed study results at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders.

Pharma giant Eli Lilly & Co is also working on an experimental drug for the disease.

More than 5 million Americans suffer from Alzheimer's. Treatments are available to help mitigate symptoms, but there is presently no cure for the disease.

[Source: The Boston Globe]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
MAR 11, 2021
Clinical & Molecular DX
Racial Disparities in ADHD Diagnoses
MAR 11, 2021
Racial Disparities in ADHD Diagnoses
Researchers have found significant racial disparities in ADHD diagnoses and treatment: Black, Hispanic, and Asian childr ...
MAR 29, 2021
Cardiology
Learning More About How Stress Breaks the Heart
MAR 29, 2021
Learning More About How Stress Breaks the Heart
Scientists are learning more about what causes a real phenomenon known as broken heart syndrome, or stress-related cardi ...
APR 17, 2021
Cannabis Sciences
Psychosis from Cannabis Use Linked to Genes for Schizophrenia
APR 17, 2021
Psychosis from Cannabis Use Linked to Genes for Schizophrenia
For some time now, cannabis users have been known to be at risk of developing psychosis more often than nonusers. Now th ...
APR 26, 2021
Cell & Molecular Biology
Stem Cell Treatment for Dementia is Promising in Model
APR 26, 2021
Stem Cell Treatment for Dementia is Promising in Model
Researchers have now determined that an experimental stem cell therapy successfully repaired brain damage and improved m ...
MAY 20, 2021
Cannabis Sciences
Cannabis Improves Symptoms in Over Half of Patients with Parkinson's Disease
MAY 20, 2021
Cannabis Improves Symptoms in Over Half of Patients with Parkinson's Disease
Researchers from the University Medical Center Hamburg-Eppendorf in Germany have found that cannabis products may produc ...
JUN 09, 2021
Drug Discovery & Development
New Drug Prevents Dementia After Head Injury
JUN 09, 2021
New Drug Prevents Dementia After Head Injury
Researchers led by the University of South Australia have identified a new drug that may be able to help prevent athlete ...
Loading Comments...